Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-1,093,500
Closed -$11.5M 43
2023
Q2
$11.5M Hold
1,093,500
1.41% 32
2023
Q1
$17.3M Buy
1,093,500
+18,863
+2% +$327K 2.15% 23
2022
Q4
$20.2M Buy
1,074,637
+112,137
+12% +$2.25M 2.57% 20
2022
Q3
$18.8M Buy
962,500
+324,500
+51% +$7.08M 2.76% 18
2022
Q2
$11.2M Buy
638,000
+215,000
+51% +$3.89M 2.46% 20
2022
Q1
$7.8M Buy
423,000
+246,000
+139% +$4.87M 1.92% 26
2021
Q4
$4.04M Buy
177,000
+62,000
+54% +$1.25M 1.64% 28
2021
Q3
$2.16M Sell
115,000
-54,857
-32% -$1.15M 1.61% 24
2021
Q2
$3.51M Buy
169,857
+857
+0.5% +$16.6K 2.43% 19
2021
Q1
$2.82M Buy
169,000
+9,000
+6% +$152K 1.95% 26
2020
Q4
$2.36M Sell
160,000
-10,000
-6% -$127K 1.64% 23
2020
Q3
$1.74M Hold
170,000
2.26% 18
2020
Q2
$1.86M Sell
170,000
-233,659
-58% -$2.41M 2.24% 18
2020
Q1
$3.1M Buy
403,659
+262,856
+187% +$2.25M 2.81% 13
2019
Q4
$1.39M Buy
+140,803
New +$1.34M 0.79% 25

Other funds holding ADTN

Harvey Partners's ADTN Position: Q3 2023 in Review

Harvey Partners sold out of Adtran (ADTN) in Q3 2023, closing a stake of 1,093,500 shares — an estimated $11.5M sold.

Harvey Partners first reported a position in ADTN in Q4 2019 and held it in 15 quarters. The position peaked at $20.2M in Q4 2022. 165 funds tracked by Wall St. Rank hold ADTN as of Q3 2023.

  • Harvey Partners reported no remaining Adtran position as of Q3 2023 after selling out during the quarter.
  • Harvey Partners sold 1,093,500 Adtran shares in Q3 2023, an estimated $11.5M.
  • Harvey Partners first reported a position in Adtran in Q4 2019 and held it in 15 quarters.
  • Harvey Partners's Adtran position peaked at $20.2M in Q4 2022.
  • 165 funds tracked by Wall St. Rank held Adtran as of Q3 2023.

Based on Harvey Partners's 13F filing for Q3 2023, filed 14 Nov 2023.